RLAY
Relay Therapeutics, Inc.
+0.50 (+2.68%)19.35USD1.2M成交股數4.2B市值–本益比(近四季)409.6股價營收比-48.3%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 350K-48% | 3.0M-61% | 7.0M | 0.00 | 677K-93% | 7.7M-768000% | 0.00-100% | 0.00-100% | 10.0M | −1K | 25.2M | 119K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 76.5M | 70.6M | 55.4M | 68.3M | 63.9M | 73.8M | 76.6M | 92.0M | 82.4M | 77.5M | 81.5M | 88.2M |
| 銷售管理費用 | 14.7M | 11.0M | 12.2M | 12.1M | 13.6M | 18.7M | 19.8M | 20.1M | 19.8M | 16.8M | 18.5M | 20.1M |
| 營業利益 | −90.8M+18% | −78.6M-7% | −60.6M-37% | −80.4M-20% | −76.8M-15% | −84.9M-8% | −96.4M+31% | −101M-5% | −90.4M | −92.2M | −73.6M | −106M |
| 營業利益率 | -25,949.7% | -2,619.7% | -866.3% | – | -11,351.1% | -1,105.2% | – | – | -903.0% | 9,219,600.0% | -291.9% | -89,117.6% |
| 稅後淨利 | −83.7M+19% | −73.3M-5% | −54.9M-38% | −74.1M-20% | −70.4M-14% | −77.1M-8% | −88.1M+34% | −92.2M-6% | −81.4M | −83.5M | −65.7M | −98.5M |
| 淨利率 | -23,916.3% | -2,443.0% | -784.3% | – | -10,395.1% | -1,003.6% | – | – | -813.3% | 8,349,500.0% | -260.8% | -82,777.3% |
| 稀釋 EPS | -0.410% | -0.41-11% | -0.31-51% | -0.43-38% | -0.41-34% | -0.46-30% | -0.63+17% | -0.69-15% | -0.62 | -0.66 | -0.54 | -0.81 |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 121M | 205M | 84.0M | 91.6M | 114M | 93.5M | 152M | 134M | 153M | 144M | 151M | 146M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | 211K | 78K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 967M | 700M | 621M | 670M | 729M | 799M | 930M | 773M | 841M | 844M | 907M | 962M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 77.4M | 57.4M | 54.3M | 62.3M | 63.2M | 78.3M | 91.3M | 90.8M | 95.7M | 92.0M | 129M | 152M |
| 股東權益 | 890M | 642M | 567M | 608M | 666M | 721M | 839M | 682M | 746M | 752M | 778M | 810M |
| 負債比 | 8.0% | 8.2% | 8.7% | 9.3% | 8.7% | 9.8% | 9.8% | 11.8% | 11.4% | 10.9% | 14.2% | 15.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −51.1M-30% | – | – | – | −73.2M | – | – | −50.3M | – | – | – |
| 資本支出 | – | – | – | – | – | 384K | – | – | 1.8M | – | – | – |
| 自由現金流 | – | – | – | – | – | −73.6M | – | – | −52.1M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -958.4% | – | – | -520.7% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 15.4M | +53.4% | −276M | -1,800.6% | -1.61 | −236M |
| FY2024 | 10.0M | -60.8% | −338M | -3,374.7% | -2.36 | −251M |
| FY2023 | 25.5M | +1749.8% | −342M | -1,338.7% | -2.79 | −304M |
| FY2022 | 1.4M | -54.4% | −291M | -21,036.1% | -2.59 | −239M |
| FY2021 | 3.0M | -96.3% | −364M | -12,012.9% | -3.82 | −77.9M |
| FY2020 | 82.7M | – | −52.4M | -63.4% | -5.40 | −104M |
| FY2019 | – | – | −75.3M | –% | -21.82 | −74.1M |